Originally published in:
https://doi.org/10.1148/radiol.2021210386
Erratum in:
https://doi.org/10.1148/radiol.2021219011
The text contained an error and has been amended as follows: The first two COVID-19 vaccines authorized for emergency use by the U.S. Food and Drug Administration are highly immunogenic, with reports of ipsilateral axillary lymphadenopathy and FDG uptake after vaccination (1,2).